Cancer incidence among workers with blood lead measurements in two countries

30.09.2019

IOM scientists Will Mueller, Peter Ritchie and Prof Damien McElvenny are amongst the co-authors of a paper entitled "Cancer incidence among workers with blood lead measurements in two countries". published in "Occupational and Environmental Medicine"

Objective Study carcinogenicity of inorganic lead, classified as ‘probably carcinogenic’ to humans by the International Agency for Research on Cancer (brain, lung, kidney and stomach).

Methods We conducted internal and external analyses for cancer incidence in two cohorts of 29 874 lead-exposed workers with past blood lead data (Finland, n=20 752, Great Britain=9122), with 6790 incident cancers. Exposure was maximum measured blood lead.

Results The combined cohort had a median maximum blood lead of 29 μg/dL, a mean first blood lead test of 1977, and was 87% male. Significant (p<0.05) positive trends, using the log of maximum blood lead, were found for brain cancer (malignant), Hodgkin’s lymphoma, lung cancer and rectal cancer, while a significant negative trend was found for melanoma. Borderline significant positive trends (0.05≤p≤0.10) were found for oesophageal cancer, meningioma and combined malignant/benign brain cancer. Categorical analyses reflected these trends. Significant interactions by country were found for lung, brain and oesophageal cancer, with Finland showing strong positive trends, and Great Britain showing modest or no trends. Larynx cancer in Finland also showed a positive trend (p=0.05). External analyses for high exposure workers (maximum blood lead >40 μg/dL) showed a significant excess for lung cancer in both countries combined, and significant excesses in Finland for brain and lung cancer. The Great Britain data were limited by small numbers for some cancers, and limited variation in exposure.

Conclusions We found strong positive incidence trends with increasing blood lead level, for several outcomes in internal analysis. Two of these, lung and brain cancer, were sites of a priori interest.

The full text of the paper is available here.

 

  • IOMworld Posted: yesterday
    We have published over 2,500 articles and major pieces of project work. Today we are one of Europe’s principal work… https://t.co/C2daujZVK7
  • IOMworld Posted: yesterday
    #NanoTox2021 is taking place online from 20th – 22nd April 2021 ➡️Nanotechnology ➡️ Hazard and risk assessment of n… https://t.co/JC30t6iKhf
  • IOMworld Posted: 2 days ago
    Talking about the physical and emotional aspects of working from home & how it impacts both organisations & humans… https://t.co/OYw7dsIvHF
  • IOMworld Posted: 3 days ago
    There is a legal duty for landlords to assess &control the risk of exposure to legionella bacteria in both domestic… https://t.co/RP4nHi3atu
  • IOMworld Posted: 6 days ago
    #NanoTox2021 is taking place online from 20th – 22nd April 2021 ➡️Nanotechnology ➡️ Hazard and risk assessment of n… https://t.co/HkPOPVzUgh
  • IOMworld Posted: 7 days ago
    Announcement: IOM's Online Face Fit Tester Training Live Workshop has been rescheduled to 1st June 10am. Join us on… https://t.co/8vfocIsDh3
  • IOMworld Posted: 7 days ago
    Join the IOM in this great opportunity to be a part of ground-breaking research on developing innovative methods fo… https://t.co/ri97lwycAP
  • IOMworld Posted: 9 days ago
    IOM talks about the physical and emotional aspects of working from home and how it impacts both organisations and h… https://t.co/cowqG7mN7M
  • IOMworld Posted: 15 days ago
    Health risks from Coronavirus and occupational disease are big issues for businesses. Our clients are benefiting fr… https://t.co/SwEyyQONfU
  • IOMworld Posted: 16 days ago
    Find out about the importance of Respirator Protection Equipment (RPE) in the workplace, join our online Face Fit T… https://t.co/AnEEVH0sVq